// App-Quantinova.ai

: Novel composite knee structure metrics of disease activity and cumulative damage predict the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative

Researchers

Presenter

  • M. Harkey

Principal Investigators

  • J. Davis

  • B. Lu

  • L. Price

  • R.J. Ward

  • J.W. MacKay

  • C.B. Eaton

  • G.H. Lo

  • M.F. Barbe

  • M. Zhang

  • J. Pang

  • A.C. Stout

  • M. LaValley

  • T.E. McAlindon

  • J.B. Driban

Medical Centers

  • Univ of Massachusetts Chan Med Sch, Worcester, MA

  • George Washington Univ, Washington D.C., DC

  • Brigham and Women’s Hospital, Boston, MA, USA

  • Univ of Cambridge Sch of Clinical Med, Cambridge, United Kingdom

  • Alpert Medical Sch of Brown Univ, Pawtucket, RI

  • Michael E DeBakey VA Med. Ctr., Houston, TX, USA

  • Baylor Col. of Med., Houston, Texas, USA

  • Drexel University, Philadelphia, PA

  • Wentworth Inst. of Technology, Boston, MA, USA

  • Pfizer Inc., Cambridge, MA

  • Northeastern Univ., Boston, MA, USA

  • Boston Univ., Boston, MA.

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Knee osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved